NCT02661126 Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030) Status COMPLETED Phase PHASE1
NCT02658279 Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype Status ACTIVE_NOT_RECRUITING Phase NA
NCT02658019 Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT02657889 Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02657148 Immediate Postpartum Nexplanon Placement in Opioid Dependent Women Status COMPLETED Phase N/A
NCT02655471 Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection Status COMPLETED Phase EARLY_PHASE1
NCT02653118 Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02652260 Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) Status COMPLETED Phase PHASE2
NCT02648503 Deep Neuromuscular Block and Sugammadex Versus Standard of Care on Quality of Recovery in Patient Undergo Elective Laparoscopic Cholecystectomy Status UNKNOWN Phase PHASE4
NCT02648477 Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT02648282 Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02645396 A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China Status COMPLETED Phase N/A
NCT02644369 Study of the Effects of Pembrolizumab in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02642809 Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers Status COMPLETED Phase PHASE1
NCT02641756 HIV Sequencing After Treatment Interruption to Identify the Clinically Relevant Anatomical Reservoir Status COMPLETED Phase NA
NCT02641093 Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02641067 A Study Evaluating the Pharmacokinetics of Doravirine (MK-1439) in Participants With Severe Renal Impairment (MK-1439-051) Status COMPLETED Phase PHASE1
NCT02638090 Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02636725 Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas Status COMPLETED Phase PHASE2
NCT02636010 Pembrolizumab (MK-3475) in MM Patients With Residual Disease Status COMPLETED Phase PHASE2